Titan Medical Inc. Stock (TMDIF) - Quote OTC Markets- MarketScreener (2024)

TITAN MEDICAL INC.

Add to a list

To use this feature you must be a member

Log inSign up

Equities

TMDIF

CA88830X8199

Delayed OTC Markets Other stock markets 03:57:28 2024-06-28 pm EDT			5-day change	1st Jan Change
0.04 ^USD	+11.11%		+10.80%	-34.43%

May. 29	Titan Medical Amends Amalgamation Agreement with Conavi Medical; Pushes Back Annual General and Special Meeting	MT
May. 29	Titan Medical Brief: Amending Amalgamation Agreement with Conavi Medical Inc.	MT

Financials (USD)

Sales 2022	-	Sales 2023	17.63	Capitalization	6.87M
Net income 2022	-42M	Net income 2023	6M	EV / Sales 2022	-
Net cash position 2022	1.58M	Net cash position 2023	6.27M	EV / Sales 2023	34,203x
P/E ratio 2022	-1.74x	P/E ratio 2023	1.01x	Employees	4
Yield 2022 *	-	Yield 2023	-	Free-Float	99.58%

More Fundamentals * Assessed data

Chart Titan Medical Inc.

Duration

Period

Style

Dynamic Chart

Latest news about Titan Medical Inc.

Titan Medical Amends Amalgamation Agreement with Conavi Medical; Pushes Back Annual General and Special Meeting	May. 29	MT
Titan Medical Brief: Amending Amalgamation Agreement with Conavi Medical Inc.	May. 29	MT
Titan Medical Brief: Says It and Conavi are "Both Working on Satisfying the Closing Conditions" As Outlined in the Amalgamation Agreement	May. 17	MT
Titan Medical Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024	May. 13	CI
Titan Medical Provides Update on Merger with Conavi	Apr. 22	MT
Titan Medical Brief: Providing Update on Planned Merger with Conavi	Apr. 22	MT
Titan Medical Brief: Upon receipt of the full US$2 million, the Contractor will deliver outstanding material, inventory, and works-in-progress to Titan	Apr. 01	MT
Titan Medical Brief: Under terms of the settlement, Co has agreed to pay the Contractor an aggregate of US$2 million, with final payment installment to be made on or before June 24, 2024	Apr. 01	MT
Titan Medical Brief: Says Entered into a settlement agreement with a contract manufacturer	Apr. 01	MT
Titan Medical Reports Fiscal Year 2023 Results	Apr. 01	MT
Titan Medical Inc. Reports Earnings Results for the Full Year Ended December 31, 2023	Apr. 01	CI
	Mar. 27
Titan Medical Announces Merger Agreement with Conavi Medical Inc.	Mar. 18	MT
Titan Medical Brief: Announcing Merger Agreement with Conavi Medical Inc.	Mar. 18	MT
Conavi Medical Inc. entered into a definitive amalgamation agreement to acquire Titan Medical Inc. for $69.8 million in a reverse merger transaction.	Mar. 17	CI

More news

Latest transcript on Titan Medical Inc.

Mar. 27

More transcripts

Analyst Recommendations on Titan Medical Inc.

Oppenheimer Downgrades Titan Medical to Perform From Outperform, Removes $3 Price Target	22-03-25	MT
TITAN MEDICAL : Oppenheimer Initiates Coverage on Titan Medical With Outperform Rating, $4 Price Target	21-04-07	MT

More recommendations

Press releases Titan Medical Inc.

Titan Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Extension of 2023 Annual General and Special Meeting	May. 29	GL
Titan Amends Amalgamation Agreement with Conavi Medical Inc. and Announces Extension of 2023 Annual General and Special Meeting	May. 29	AQ
Titan Provides Update on Planned Merger with Conavi	May. 17	GL
Titan Medical Reports Financial Results for the First Quarter 2024	May. 13	GL
Titan Provides Update on Planned Merger with Conavi	Apr. 22	GL

More press releases

Quotes and Performance

1 day	+11.11%
1 week	+10.80%
1 month	+13.31%
3 months	-22.33%
6 months	-34.43%
Current year	-34.43%

More quotes

Highs and lows

1 week

Managers and Directors - Titan Medical Inc.

Managers	Title	Age	Since
Paul Cataford CEO	Chief Executive Officer	60	20-09-29
Chien Huang DFI	Director of Finance/CFO	-	-
Cary Vance BRD	Director/Board Member	58	20-09-29

Members of the board	Title	Age	Since
Paul Cataford CEO	Chief Executive Officer	60	20-09-29
Anthony Giovinazzo BRD	Director/Board Member	67	20-09-29
Cary Vance BRD	Director/Board Member	58	20-09-29

More insiders

Quotes

Date	Price	Change	Volume
24-06-28	0.04	+11.11%	4,615
24-06-27	0.036	-0.83%	5,162
24-06-26	0.0363	-2.68%	44,678
24-06-25	0.0373	+3.32%	58,174
24-06-24	0.0361	-.--%	29,556

Delayed Quote OTC Markets, June 28, 2024 at 03:57 pm EDT

More quotes

Company Profile

Titan Medical Inc. is a medical technology company. The Company is focused on the development and commercialization of surgical technologies for single access robotic assisted surgery (RAS) requiring only a single patient access point. It has integrated technology into the Enos surgical system with the purpose of enhancing the robotic assisted surgical experience for surgeons. The Enos surgeon workstation includes a three dimensional (3D) high-definition display to provide a crucial balance of surgical immersion and situational awareness in the operating room. The display is mounted to the ergonomic workstation with a natural handle interface designed to deliver and support comfortable surgical posture, even during long procedures. The Company's multi-articulated instruments bring fluid flexibility and strength to position the end effectors for grasping, suturing, cutting and coagulation.

Sector

Calendar

2024-08-07 - Q2 2024 Earnings Release (Projected)

More about the company

Income Statement Evolution

More financial data

Annual profits - Rate of surprise

Company calendar

	1st Jan change	Capi.
THERMO FISHER SCIENTIFIC	+4.18%	211B
DANAHER CORPORATION	+8.00%	185B
INTUITIVE SURGICAL, INC.	+31.86%	158B
SIEMENS HEALTHINEERS AG	+2.47%	64.32B
EDWARDS LIFESCIENCES CORPORATION	+21.14%	55.66B
SHENZHEN MINDRAY BIO-MEDICAL ELECTRONICS CO., LTD.	+0.11%	48.41B
AGILENT TECHNOLOGIES, INC.	-6.76%	37.82B
GE HEALTHCARE TECHNOLOGIES INC.	+0.78%	35.57B
RESMED, INC.	+11.28%	28.12B

Stock Market
Equities
TMD Stock
TMDIF Stock

Secure and Increase the Performance of your Investments with our Team of Experts at your Side Securing my Investments

"); for (var element in ICConf) { if (document.getElementById("zpp"+element)) { document.getElementById("zpp"+element).innerHTML = ""; } } InvestingChannelQueue.push(function() { ic_page = InvestingChannel.UAT.Run("5c5a75c3-8896-4592-98f8-dc06e6fdcc56"); }); } gaEvent('adspv', 'InvestingChannel_v2', 'US');googletag.cmd.push(function() { googletag.pubads().setTargeting('Edition', 'en_US');googletag.pubads().setTargeting('UserType', 'free');googletag.pubads().setTargeting('Content', 'equities');googletag.pubads().setTargeting('codezb', '44439011');googletag.enableServices();googletag.pubads().collapseEmptyDivs();try{googletag.pubads().getSlots().forEach(function(slot){if(slot.getSlotElementId().startsWith('zpp')){;}else{googletag.pubads().refresh([slot],{changeCorrelator: false});}})}catch(error){console.error(error)}});$(document).ready(function() { $( document).on('zbv_visible',function () {startAdsService();}); if (document[zbv_hidden]===false) { startAdsService(); } });